| UniProt ID | RBM7_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y580 | |
| Protein Name | RNA-binding protein 7 | |
| Gene Name | RBM7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 266 | |
| Subcellular Localization | Nucleus . Excluded from the nucleolus. | |
| Protein Description | Subunit of the trimeric nuclear exosome targeting (NEXT) complex, a complex that directs a subset of non-coding short-lived RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor MTREX, which links to RNA-binding protein adapters. [PubMed: 27871484 Possible involved in germ cell RNA processing and meiosis (Probable] | |
| Protein Sequence | MGAAAAEADRTLFVGNLETKVTEELLFELFHQAGPVIKVKIPKDKDGKPKQFAFVNFKHEVSVPYAMNLLNGIKLYGRPIKIQFRSGSSHAPQDVSLSYPQHHVGNSSPTSTSPSRYERTMDNMTSSAQIIQRSFSSPENFQRQAVMNSALRQMSYGGKFGSSPLDQSGFSPSVQSHSHSFNQSSSSQWRQGTPSSQRKVRMNSYPYLADRHYSREQRYTDHGSDHHYRGKRDDFFYEDRNHDDWSHDYDNRRDSSRDGKWRSSRH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MGAAAAEAD ------CCHHHHHCC | 24.75 | 25489052 | |
| 11 | Phosphorylation | AAAEADRTLFVGNLE HHHHCCCEEEECCCC | 25.70 | 20068231 | |
| 19 | Phosphorylation | LFVGNLETKVTEELL EEECCCCCHHCHHHH | 33.70 | 20068231 | |
| 45 | "N6,N6-dimethyllysine" | KVKIPKDKDGKPKQF EEECCCCCCCCCCEE | 74.61 | - | |
| 45 | Methylation | KVKIPKDKDGKPKQF EEECCCCCCCCCCEE | 74.61 | - | |
| 48 | Acetylation | IPKDKDGKPKQFAFV CCCCCCCCCCEEEEE | 60.21 | 7662453 | |
| 50 | Acetylation | KDKDGKPKQFAFVNF CCCCCCCCEEEEEEE | 62.63 | 7662465 | |
| 58 | Acetylation | QFAFVNFKHEVSVPY EEEEEEEEEEECHHH | 33.38 | 7662477 | |
| 65 | Phosphorylation | KHEVSVPYAMNLLNG EEEECHHHHHHHHCC | 19.14 | 20860994 | |
| 81 | Ubiquitination | KLYGRPIKIQFRSGS EEECEEEEEEECCCC | 32.89 | - | |
| 86 | Phosphorylation | PIKIQFRSGSSHAPQ EEEEEECCCCCCCCC | 44.29 | 27080861 | |
| 88 | Phosphorylation | KIQFRSGSSHAPQDV EEEECCCCCCCCCEE | 21.87 | 27080861 | |
| 89 | Phosphorylation | IQFRSGSSHAPQDVS EEECCCCCCCCCEEE | 27.48 | 27080861 | |
| 96 | Phosphorylation | SHAPQDVSLSYPQHH CCCCCEEEECCCCCC | 21.64 | 27732954 | |
| 98 | Phosphorylation | APQDVSLSYPQHHVG CCCEEEECCCCCCCC | 27.53 | 29978859 | |
| 99 | Phosphorylation | PQDVSLSYPQHHVGN CCEEEECCCCCCCCC | 16.53 | 29978859 | |
| 107 | Phosphorylation | PQHHVGNSSPTSTSP CCCCCCCCCCCCCCH | 31.59 | 23401153 | |
| 108 | Phosphorylation | QHHVGNSSPTSTSPS CCCCCCCCCCCCCHH | 35.88 | 21712546 | |
| 110 | Phosphorylation | HVGNSSPTSTSPSRY CCCCCCCCCCCHHHH | 46.73 | 21712546 | |
| 111 | Phosphorylation | VGNSSPTSTSPSRYE CCCCCCCCCCHHHHH | 30.21 | 23663014 | |
| 112 | Phosphorylation | GNSSPTSTSPSRYER CCCCCCCCCHHHHHH | 47.32 | 21712546 | |
| 113 | Phosphorylation | NSSPTSTSPSRYERT CCCCCCCCHHHHHHH | 22.20 | 21712546 | |
| 115 | Phosphorylation | SPTSTSPSRYERTMD CCCCCCHHHHHHHHC | 47.46 | 21712546 | |
| 117 | Phosphorylation | TSTSPSRYERTMDNM CCCCHHHHHHHHCCC | 17.69 | 29449344 | |
| 120 | Phosphorylation | SPSRYERTMDNMTSS CHHHHHHHHCCCCCH | 19.55 | 22199227 | |
| 121 | Sulfoxidation | PSRYERTMDNMTSSA HHHHHHHHCCCCCHH | 4.37 | 21406390 | |
| 125 | Phosphorylation | ERTMDNMTSSAQIIQ HHHHCCCCCHHHHHH | 26.28 | 22199227 | |
| 126 | O-linked_Glycosylation | RTMDNMTSSAQIIQR HHHCCCCCHHHHHHH | 16.95 | 31492838 | |
| 126 | Phosphorylation | RTMDNMTSSAQIIQR HHHCCCCCHHHHHHH | 16.95 | 22199227 | |
| 127 | Phosphorylation | TMDNMTSSAQIIQRS HHCCCCCHHHHHHHH | 18.28 | 22199227 | |
| 134 | Phosphorylation | SAQIIQRSFSSPENF HHHHHHHHCCCHHHH | 17.07 | 30266825 | |
| 135 | Phosphorylation | AQIIQRSFSSPENFQ HHHHHHHCCCHHHHH | 10.25 | 20058876 | |
| 136 | Phosphorylation | QIIQRSFSSPENFQR HHHHHHCCCHHHHHH | 46.35 | 25159151 | |
| 137 | Phosphorylation | IIQRSFSSPENFQRQ HHHHHCCCHHHHHHH | 33.93 | 19664994 | |
| 138 | Phosphorylation | IQRSFSSPENFQRQA HHHHCCCHHHHHHHH | 39.08 | 19664994 | |
| 143 | Methylation | SSPENFQRQAVMNSA CCHHHHHHHHHHHHH | 23.45 | 115490823 | |
| 144 | Methylation | SPENFQRQAVMNSAL CHHHHHHHHHHHHHH | 27.76 | - | |
| 149 | Phosphorylation | QRQAVMNSALRQMSY HHHHHHHHHHHHHHC | 15.58 | 21815630 | |
| 150 | Phosphorylation | RQAVMNSALRQMSYG HHHHHHHHHHHHHCC | 11.19 | - | |
| 152 | Methylation | AVMNSALRQMSYGGK HHHHHHHHHHHCCCC | 29.85 | 24129315 | |
| 153 | Methylation | VMNSALRQMSYGGKF HHHHHHHHHHCCCCC | 26.48 | - | |
| 155 | Phosphorylation | NSALRQMSYGGKFGS HHHHHHHHCCCCCCC | 16.58 | 28857561 | |
| 156 | Phosphorylation | SALRQMSYGGKFGSS HHHHHHHCCCCCCCC | 25.26 | 23312004 | |
| 159 | Acetylation | RQMSYGGKFGSSPLD HHHHCCCCCCCCCCC | 42.04 | 25953088 | |
| 162 | Phosphorylation | SYGGKFGSSPLDQSG HCCCCCCCCCCCCCC | 31.73 | 22199227 | |
| 163 | Phosphorylation | YGGKFGSSPLDQSGF CCCCCCCCCCCCCCC | 29.84 | 22199227 | |
| 164 | Phosphorylation | GGKFGSSPLDQSGFS CCCCCCCCCCCCCCC | 41.47 | - | |
| 168 | Phosphorylation | GSSPLDQSGFSPSVQ CCCCCCCCCCCCCHH | 41.28 | 22199227 | |
| 169 | Phosphorylation | SSPLDQSGFSPSVQS CCCCCCCCCCCCHHC | 22.78 | - | |
| 171 | Phosphorylation | PLDQSGFSPSVQSHS CCCCCCCCCCHHCCC | 21.57 | 22199227 | |
| 172 | Phosphorylation | LDQSGFSPSVQSHSH CCCCCCCCCHHCCCC | 35.94 | - | |
| 173 | Phosphorylation | DQSGFSPSVQSHSHS CCCCCCCCHHCCCCC | 31.43 | 29523821 | |
| 176 | Phosphorylation | GFSPSVQSHSHSFNQ CCCCCHHCCCCCCCC | 25.46 | 22199227 | |
| 178 | Phosphorylation | SPSVQSHSHSFNQSS CCCHHCCCCCCCCCC | 26.52 | 22199227 | |
| 179 | Phosphorylation | PSVQSHSHSFNQSSS CCHHCCCCCCCCCCC | 30.87 | - | |
| 180 | Phosphorylation | SVQSHSHSFNQSSSS CHHCCCCCCCCCCCC | 28.98 | 22199227 | |
| 181 | Phosphorylation | VQSHSHSFNQSSSSQ HHCCCCCCCCCCCCC | 8.91 | - | |
| 184 | Phosphorylation | HSHSFNQSSSSQWRQ CCCCCCCCCCCCCCC | 33.04 | 22199227 | |
| 185 | Phosphorylation | SHSFNQSSSSQWRQG CCCCCCCCCCCCCCC | 25.01 | 22199227 | |
| 186 | Phosphorylation | HSFNQSSSSQWRQGT CCCCCCCCCCCCCCC | 31.62 | 22199227 | |
| 187 | Phosphorylation | SFNQSSSSQWRQGTP CCCCCCCCCCCCCCC | 35.39 | 22199227 | |
| 190 | Dimethylation | QSSSSQWRQGTPSSQ CCCCCCCCCCCCCHH | 19.88 | - | |
| 190 | Methylation | QSSSSQWRQGTPSSQ CCCCCCCCCCCCCHH | 19.88 | 80702625 | |
| 191 | Methylation | SSSSQWRQGTPSSQR CCCCCCCCCCCCHHH | 58.09 | - | |
| 193 | Phosphorylation | SSQWRQGTPSSQRKV CCCCCCCCCCHHHHH | 16.20 | 21406692 | |
| 195 | Phosphorylation | QWRQGTPSSQRKVRM CCCCCCCCHHHHHCC | 38.65 | 21406692 | |
| 196 | Phosphorylation | WRQGTPSSQRKVRMN CCCCCCCHHHHHCCC | 34.90 | 21406692 | |
| 198 | Methylation | QGTPSSQRKVRMNSY CCCCCHHHHHCCCCC | 41.19 | 24412129 | |
| 198 | Dimethylation | QGTPSSQRKVRMNSY CCCCCHHHHHCCCCC | 41.19 | - | |
| 199 | Methylation | GTPSSQRKVRMNSYP CCCCHHHHHCCCCCH | 26.93 | 115490807 | |
| 200 | Methylation | TPSSQRKVRMNSYPY CCCHHHHHCCCCCHH | 8.38 | - | |
| 201 | Methylation | PSSQRKVRMNSYPYL CCHHHHHCCCCCHHH | 22.92 | 54558675 | |
| 202 | Methylation | SSQRKVRMNSYPYLA CHHHHHCCCCCHHHH | 4.35 | - | |
| 204 | Phosphorylation | QRKVRMNSYPYLADR HHHHCCCCCHHHHHC | 20.38 | 23401153 | |
| 205 | Phosphorylation | RKVRMNSYPYLADRH HHHCCCCCHHHHHCC | 7.29 | 25159151 | |
| 206 | Phosphorylation | KVRMNSYPYLADRHY HHCCCCCHHHHHCCC | 19.92 | - | |
| 207 | Phosphorylation | VRMNSYPYLADRHYS HCCCCCHHHHHCCCC | 13.29 | 23312004 | |
| 211 | Methylation | SYPYLADRHYSREQR CCHHHHHCCCCCCHH | 25.65 | 115490815 | |
| 212 | Methylation | YPYLADRHYSREQRY CHHHHHCCCCCCHHH | 26.01 | - | |
| 246 | Phosphorylation | DRNHDDWSHDYDNRR CCCCCCCCCCCCCCC | 17.30 | 20873877 | |
| 260 | Acetylation | RDSSRDGKWRSSRH- CCCCCCCCCCCCCC- | 43.66 | 30591829 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 136 | S | Phosphorylation |
| 25189701 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136; SER-137 ANDSER-204, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-136 ANDSER-137, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-137, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY. | |